Raptor Pharmaceutical Corp Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 30 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-10-25: Reporting owner Bruhn Suzanne Louise; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-10-25: Reporting owner Bruhn Suzanne Louise; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-10-25: Reporting owner GEMAYEL GEORGES; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-10-25: Reporting owner Happel David; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-10-25 | Bruhn Suzanne Louise Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −90,000 0 owned after | $5.13 exercise price | 2016-10-26 | |
| 2016-10-25 | Bruhn Suzanne Louise Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,680 0 owned after | $5.49 exercise price | 2016-10-26 | |
| 2016-10-25 | GEMAYEL GEORGES Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,915 0 owned after | $5.22 exercise price | 2016-10-26 | |
| 2016-10-25 | Happel David Officer (Chief Commercial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −93,784 0 owned after | $3.74 exercise price | 2016-10-26 | |
| 2016-10-25 | Smith Michael P Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −84,751 0 owned after | $3.74 exercise price | 2016-10-26 | |
| 2016-10-25 | Gould Ashley C. Officer (Chief Legal Officer) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,054 0 owned after | $3.74 exercise price | 2016-10-26 | |
| 2016-10-25 | LAPOINTE ANTHONY GREGG Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,915 0 owned after | $5.22 exercise price | 2016-10-26 | |
| 2016-10-25 | Anderson Raymond Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $2.97 exercise price | 2016-10-26 | |
| 2016-10-25 | Anderson Raymond Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −90,000 0 owned after | $3.54 exercise price | 2016-10-26 | |
| 2016-10-25 | Anderson Raymond Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −120,000 0 owned after | $5.13 exercise price | 2016-10-26 | |
| 2016-10-25 | Anderson Raymond Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $5.49 exercise price | 2016-10-26 | |
| 2016-10-25 | Smith Julie Director, Officer (President and CEO) | 4 | Stock Option(right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −152,050 0 owned after | $5.27 exercise price | 2016-10-26 | |
| 2016-10-25 | Smith Julie Director, Officer (President and CEO) | 4 | Stock Option(right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −175,000 0 owned after | $8.13 exercise price | 2016-10-26 | |
| 2016-10-25 | Smith Julie Director, Officer (President and CEO) | 4 | Stock Option(right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −240,595 0 owned after | $3.74 exercise price | 2016-10-26 | |
| 2016-10-25 | Keltner Llew Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −74,164 0 owned after | $3.54 exercise price | 2016-10-26 | |
| 2016-10-25 | Keltner Llew Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −120,000 0 owned after | $5.13 exercise price | 2016-10-26 | |
| 2016-10-25 | Keltner Llew Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $5.49 exercise price | 2016-10-26 | |
| 2016-10-25 | FRANKLIN RICHARD L Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −90,000 0 owned after | $3.54 exercise price | 2016-10-26 | |
| 2016-10-25 | FRANKLIN RICHARD L Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −120,000 0 owned after | $5.13 exercise price | 2016-10-26 | |
| 2016-10-25 | FRANKLIN RICHARD L Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $5.49 exercise price | 2016-10-26 | |
| 2016-10-25 | STARR CHRISTOPHER M Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −460,064 0 owned after | $5.13 exercise price | 2016-10-26 | |
| 2016-10-25 | STARR CHRISTOPHER M Director | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −150,000 0 owned after | $5.49 exercise price | 2016-10-26 | |
| 2016-10-25 | Polu Krishna R Officer (Chief Medical Officer) | 4 | Stock Option(right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −89,152 0 owned after | $3.74 exercise price | 2016-10-26 | |
| 2016-04-15 | LAPOINTE ANTHONY GREGG Director | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,915 7,915 owned after | $5.22 exercise price | 2016-04-19 | |
| 2016-04-15 | GEMAYEL GEORGES Director | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,915 7,915 owned after | $5.22 exercise price | 2016-04-19 | |
| 2016-02-09 | Polu Krishna R Officer (Chief Medical Officer) | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +89,152 89,152 owned after | $3.74 exercise price | 2016-02-11 | |
| 2016-02-09 | Happel David Officer (Chief Commerical Officer) | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +93,784 93,784 owned after | $3.74 exercise price | 2016-02-11 | |
| 2016-02-09 | Gould Ashley C. Officer (SVP Gen Counsel-CorpGovernance) | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,054 44,054 owned after | $3.74 exercise price | 2016-02-11 | |
| 2016-02-09 | Smith Michael P Officer (Chief Financial Officer) | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +84,751 84,751 owned after | $3.74 exercise price | 2016-02-11 | |
| 2016-02-09 | Smith Julie Director, Officer (President and CEO) | 4 | Stock options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +240,595 240,595 owned after | $3.74 exercise price | 2016-02-11 |